Bejarano-Quisoboni Daniel, Pelletier-Fleury Nathalie, Allodji Rodrigue S, Lacour Brigitte, GrosClaude Pascale, Pacquement Hélène, Doz François, Berchery Delphine, Pluchart Claire, Bondiau Piere-Yves, Nys Julie, Jackson Angela, Demoor-Goldschmidt Charlotte, Dumas Agnès, Thomas-Teinturier Cécile, Vu-Bezin Giao, Valteau-Couanet Dominique, Haddy Nadia, Fresneau Brice, de Vathaire Florent
Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.
Primary care and Prevention Team, CESP, Inserm U1018, Villejuif, France.
PLoS One. 2022 May 26;17(5):e0267317. doi: 10.1371/journal.pone.0267317. eCollection 2022.
Childhood cancer survivors (CCS) may require lifelong medical care due to late effects of cancer treatments. Little is known about of their healthcare utilization and expenditures at long-term especially in publicly funded health care system. We aim to estimate and describe the health care expenditures among long-term CCS in France.
A total of 5319 five-year solid CCS diagnosed before the age of 21 between 1945 and 2000 in France were identified in the French Childhood Cancer Survivors Study cohort (FCCSS) and the French cancer registry. Information about health care expenditure was taken from the French national health data system between 2011 and 2016, and was described according to survivors' characteristics. Generalized linear models were used to determine associations between health care expenditures and survivors' characteristics.
Mean annual amount of healthcare expenditures was € 4,255. Expenditures on hospitalizations and pharmacy represents 60% of total expenditures. Mean annual of healthcare expenditures were higher at increasing age, among women survivors (€ 4,795 vs € 3,814 in men) and in central nervous system (CNS) tumor survivors (€ 7,116 vs € 3,366 in lymphoma and € 3,363 in other solid tumor survivors).
Childhood cancer survivorship is associated with a substantial economic burden in France. We found that female gender and CNS primary cancer were associated with increased healthcare expenditures.
儿童癌症幸存者(CCS)由于癌症治疗的晚期效应可能需要终身医疗护理。对于他们长期的医疗保健利用情况和支出,尤其是在公共资助的医疗保健系统中,人们了解甚少。我们旨在估计和描述法国长期儿童癌症幸存者的医疗保健支出情况。
在法国儿童癌症幸存者研究队列(FCCSS)和法国癌症登记处中,确定了1945年至2000年间在法国21岁之前被诊断出患有五年期实体癌的5319名儿童癌症幸存者。关于医疗保健支出的信息取自2011年至2016年的法国国家卫生数据系统,并根据幸存者的特征进行描述。使用广义线性模型来确定医疗保健支出与幸存者特征之间的关联。
医疗保健支出的年均金额为4255欧元。住院和药房支出占总支出的60%。随着年龄增长,女性幸存者(4795欧元,男性为3814欧元)以及中枢神经系统(CNS)肿瘤幸存者(7116欧元,淋巴瘤幸存者为3366欧元,其他实体肿瘤幸存者为3363欧元)的医疗保健年均支出更高。
在法国,儿童癌症幸存者面临着巨大的经济负担。我们发现女性性别和中枢神经系统原发性癌症与医疗保健支出增加有关。